Transcription Factor ATF2 Regulation by the JNK Signal Transduction Pathway

Shashi Kumar Gupta(University of Massachusetts Chan Medical School), Debra Campbell(University of Massachusetts Chan Medical School), Benoit Dérijard(Howard Hughes Medical Institute), Roger J. Davis(Howard Hughes Medical Institute)
Science
January 20, 1995
Cited by 1,455

Abstract

Treatment of cells with pro-inflammatory cytokines or ultraviolet radiation causes activation of the c-Jun NH2-terminal protein kinase (JNK). Activating transcription factor-2 (ATF2) was found to be a target of the JNK signal transduction pathway. ATF2 was phosphorylated by JNK on two closely spaced threonine residues within the NH2-terminal activation domain. The replacement of these phosphorylation sites with alanine inhibited the transcriptional activity of ATF2. These mutations also inhibited ATF2-stimulated gene expression mediated by the retinoblastoma (Rb) tumor suppressor and the adenovirus early region 1A (E1A) oncoprotein. Furthermore, expression of dominant-negative JNK inhibited ATF2 transcriptional activity. Together, these data demonstrate a role for the JNK signal transduction pathway in transcriptional responses mediated by ATF2.


Related Papers

No related papers found

Powered by citation graph analysis